Dianthus Therapeutics 320% Year: What Investors Should Know as Stakes Shift
Dianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
Minimizing spending doesn’t have to be a challenge. Explore effortless ways to keep your expenses low while enjoying life.
22,570 articlesDianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
Burlington Stores keeps evolving in a crowded value retail market. After Q1 2026, investors should focus on margins, ...
Nexstar's chief executive warns that the era of local news funding through traditional ads may be ending. He says the...
The rental market is shifting: entry-level homes are harder to find, and renters struggle to afford them. This guide ...
Markets recalibrate after a run by the Magnificent Seven, pushing many to rethink concentration. Three ETFs—RSP, SCHV...
Prediction markets are moving into the mainstream. This piece examines whether Polymarket likely 2026? could bring an...
When a major momentum bet is unwound, it sends signals about risk tolerance and market breadth. This article explains...
One investor started with a single rental six years ago and now closes about 24 deals each year. This story breaks do...
Point launches a third-party origination channel for its HEI product and names Samuel Bjelac as wholesale chief, aimi...
A disciplined AI stock approach blends deep research with risk controls. Learn how this fund manager brilliant method...
AI memory demand is reshaping a sleepy sector. Learn how to gain exposure to Samsung, Hynix, and Micron with a smart,...
Private credit funds are tightening access to withdrawals through redemption limits. This article explains the mechan...